USD10
NRXS Shares
About NeuraxisNeuraxis Inc is a growth-stage medical technology company focused on neuromodulation therapies for chronic and debilitating conditions in the gastrointestinal (GI) digestive system, specifically from disorders of the gut-brain interaction (DGBIs) in pediatrics and adults. The company is dedicated to advancing the science with its' proprietary Percutaneous Electrical Nerve Field Stimulation (PENFS) technology. The company focuses on targeted therapies for the pediatric and adolescent population suffering from disorders of gut-brain interaction (DGBIs).
USD10
NRXS Shares
About NeuraxisNeuraxis Inc is a growth-stage medical technology company focused on neuromodulation therapies for chronic and debilitating conditions in the gastrointestinal (GI) digestive system, specifically from disorders of the gut-brain interaction (DGBIs) in pediatrics and adults. The company is dedicated to advancing the science with its' proprietary Percutaneous Electrical Nerve Field Stimulation (PENFS) technology. The company focuses on targeted therapies for the pediatric and adolescent population suffering from disorders of gut-brain interaction (DGBIs).
Stats
TRADING WINDOW
Closed
OPENS AT
Not enough data
MARKET CAP
$77.98M
OPEN PRICE
$6.27
LOW (1Y)
$2.20
HIGH (1Y)
$9.33
LOW (24H)
$6.14
HIGH (24H)
$6.37
VOLUME (24H)
$42.49K
74.38%
Price history
Time | Price | Change |
|---|---|---|
Today | $6.27 | |
1 Day | $6.25 | 0.00% |
1 Week | $6.82 | |
1 Month | $7.16 | |
1 Year | $2.52 |
Past performance is not a reliable indicator of future results.
Discover more
Popular cryptocurrencies
Legal
Information is provided for informational purposes only, and is not investment advice. This is not an invitation, inducement or recommendation to buy any particular asset, or to employ any particular investment strategy. Coinbase makes no representation as to the accuracy, suitability or validity of any information provided.All ticker names are trademarks of their respective holders. Any ticker reference does not imply affiliate with or endorsement by a third-party. Real-time prices are sourced from third parties, but not from all markets. Source: Nasdaq Last Sale. Morningstar data ©2026.
